pharmalot· @pharmalot · X·· 15 天前AI 评分12
AI 导读
Pharmalot.. Pharmalittle.. 早安:我们正在阅读关于向俄罗斯中间人付款、Dupixent 潜在竞品及更多新闻的内容.. https://www.statnews.com/pharmalot/2026/11/02/drugmaker-payments-to-russian-middlemen-possible-dupixent-rival/ #pharma #Russia #Merck #AstraZeneca #Novartis #EliLilly #Sanofi #Dupixent #Pfizer #shortages #antibiotics #pharmacy #CVS
正文
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about payments to Russian middlemen, a possible Dupixent rival and more news.. https://www.statnews.com/pharmalot/2026/11/02/drugmaker-payments-to-russian-middlemen-possible-dupixent-rival/ #pharma #Russia #Merck #AstraZeneca #Novartis #EliLilly #Sanofi #Dupixent #Pfizer #shortages #antibiotics #pharmacy #CVS
来源:pharmalot · x.com